What does DailyMed say about bethanechol contraindications (including ileus)?
Bethanechol (a cholinergic agonist) is listed on DailyMed with contraindications that include mechanical intestinal or urinary obstruction, and conditions where increased bowel activity could worsen obstruction. This is why ileus is treated as a key “avoid” scenario: ileus is a functional blockage of the intestines, and cholinergic stimulation can worsen abdominal distension or delay resolution if the bowel is not actually moving normally. [1]
Is ileus specifically listed as a contraindication, or is it covered under obstruction warnings?
DailyMed’s contraindication language is framed around obstruction rather than naming every possible intestinal motility disorder. Practically, that means prescribers treat ileus as a contraindicated/avoided use because it is an intestinal non-motility state that can behave like a functional obstruction. [1]
Why are cholinergic drugs like bethanechol a problem in ileus?
Bethanechol increases gastrointestinal motility and bladder contraction activity. In ileus, the intestine is not propelling contents effectively; stimulating motility can increase symptoms and potentially worsen complications when the underlying problem is impaired motility rather than a treatable lack of cholinergic stimulation. This clinical logic aligns with the DailyMed contraindication approach centered on obstruction/blocked flow. [1]
What does this mean for patients being treated for urinary retention?
Bethanechol is often used for urinary retention related to decreased bladder tone, but obstructive uropathy is a contraindication. If a patient instead has another cause of urinary retention (for example, mechanical blockage), bethanechol can be unsafe. The same “don’t stimulate when there’s obstruction” principle is applied to both the GI tract (including ileus as a functional obstruction) and the urinary tract. [1]
What alternatives are commonly considered when ileus is present?
If ileus is suspected or confirmed, clinicians typically focus on supportive care and treating the underlying cause (for example, stopping offending agents, correcting electrolytes, and bowel rest). In that setting, bethanechol is generally avoided because it conflicts with the goal of letting bowel function recover. DailyMed’s contraindication framework supports this avoidance in patients with intestinal obstruction-type conditions. [1]
Sources:
[1] https://dailymed.nlm.nih.gov/dailymed/